Overexpression of NR1D1 Portends Disease Recurrence in Thyroid Cancer
NR1D1 is overexpressed in malignant thyroid tumors and has prognostic significance. Our findings suggest therapeutic potential in targeting NR1D1 for thyroid cancer.
Authors
- Shih‐Ping Cheng (ORCID: https://orcid.org/0000-0002-6301-5096)
- Shao‐Chiang Chang (ORCID: https://orcid.org/0000-0002-4866-0433)
- Chi‐Yu Kuo
- Shih‐Yuan Huang (ORCID: https://orcid.org/0000-0002-5068-8304)
- Yi‐Chiung Hsu
- Ming-Nan Chien
- Jie‐Yang Jhuang
Institutions
- National Central University (TW)
- Mackay Memorial Hospital (TW)
- Mackay Medical University (TW)
- Institute of Biomedical Science (GB)
- Taipei Medical University (TW)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2024-10-03
- DOI
- https://doi.org/10.1210/clinem/dgae687
- Citations
- 7
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.50
Funders
- Mackay Memorial Hospital